Correlation analysis between UAP1L1 expression and clinical characteristics in patients with prostate cancer revealed that there were significant differences in the expression of UAP1L1 in pathology grade, Gleason score and Gleason grade (Table 2). This evidence concerns the gene UAP1L1 and Familial prostate cancer.